AFT reports 32% rise in gross profit

money profit income revenue
The pharmaceutical company has also seen a 16% growth in revenue, as it launches Maxigesic across several countries AFT Pharmaceuticals has announced its full-year audited financial results for the year ending 31 March 2018 (FY2018). “The FY2018 results reflect the significant progress on development and commercialisation of our key innovative products in addition to expanding

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Down to the final 16
Next Let us in: Guild